ConductScience.org, home

Trial · NCT02603328

Participant flow14

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDTreatment 80mg41
Overall StudySTARTEDPlacebo39
Overall StudyCompleted Year 1Treatment 80mg34
Overall StudyCompleted Year 1Placebo36
Overall StudyLowered to 40mg Dose in Year 1Treatment 80mg1
Overall StudyLowered to 40mg Dose in Year 1Placebo0
Overall StudyCompleted Year 2Treatment 80mg31
Overall StudyCompleted Year 2Placebo31
Overall StudyLowered to 40mg Dose in Year 2Treatment 80mg0
Overall StudyLowered to 40mg Dose in Year 2Placebo0
Overall StudyCOMPLETEDTreatment 80mg31
Overall StudyCOMPLETEDPlacebo31
Overall StudyNOT COMPLETEDTreatment 80mg10
Overall StudyNOT COMPLETEDPlacebo8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02603328/flow